Denosumab A human monoclonal antibody that prevents RANKL-RANK interaction Denosumab (Bone Metabolism Regulator) Denosumab is a new class of osteoporosis treatment called a human monoclonal antibody that prevents RANKL-RANK interaction […]

Their Royal Highnesses The Prince of Wales and The Duchess of Cornwall toured Canada from May 17 to 19, 2022 which included a special evening reception at Rideau Hall, hosted by the Governor General of Canada, Her Excellency the Right Honourable Mary Simon.

In a study published on Oct 28, 2014 by Dr. Michaelsson of Uppsala University, Sweden in the BMJ, high milk intake was associated with an increased rate of death in […]

Medications that can Cause Bone Loss, Falls and/or Fractures A variety of medications can increase bone loss and/or fall risk: Synthetic Glucocorticoids (e.g. Prednisone) Glucocorticoids are produced naturally by the […]

Frequently Asked Questions What causes osteoporosis? No single cause for osteoporosis has been identified. However, certain factors – called risk factors – do seem to play a role in the […]

Fracture Risk Scale An innovative tool for assessing & managing fracture risk in long-term care Did you know? WHY IS PREVENTING FRACTURES IN LONG-TERM CARE IMPORTANT? The fracture rate in […]

FRACTURE RISK ASSESSMENT Determining your risk of breaking a bone Rather than relying solely on the results of a bone mineral density (BMD) test to make treatment decisions for osteoporosis, […]

On Oct 28, 2014 a study on milk was published by Dr. Michaelsson of Uppsala University in Sweden. This study claims that high milk intake was associated with an increased […]

Healthcare Providers Guideline and Recommendations Find information and links to the 2023 Clinical Practice Guideline and Exercise and Long-Term Care Recommendations. Learn about Osteoporosis Canada’s Scientific Advisory Council (SAC). VIEW […]